Condition
Carcinoma, Basal Cell (BCC)
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 4 (1)
Trial Status
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07501780Not Yet Recruiting
Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice
NCT06880848Phase 4CompletedPrimary
Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China
NCT02587819Phase 1CompletedPrimary
Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment
Showing all 3 trials